AXGN

AXGN

USD

Axogen Inc. Common Stock

$23.770+0.710 (3.079%)

Цена в режиме реального времени

Healthcare
Медицинские приборы
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$23.060

Максимум

$23.830

Минимум

$22.920

Объем

0.27M

Фундаментальные показатели компании

Рыночная капитализация

1.1B

Отрасль

Медицинские приборы

Страна

United States

Статистические данные торговли

Средний объем

1.10M

Биржа

NCM

Валюта

USD

52-недельный диапазон

Минимум $9.22Текущая $23.770Максимум $23.83

Связанные новости

GlobeNewswire

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

ALACHUA, Fla. and TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

Просмотреть больше
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $26

HC Wainwright & Co. analyst Yi Chen maintains Axogen with a Buy and raises the price target from $25 to $26.

Просмотреть больше
HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $26
Analyst Upgrades

Raymond James Maintains Outperform on Axogen, Raises Price Target to $27

Raymond James analyst Jayson Bedford maintains Axogen with a Outperform and raises the price target from $20 to $27.

Просмотреть больше
Raymond James Maintains Outperform on Axogen, Raises Price Target to $27
Analyst Upgrades

Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $27

Canaccord Genuity analyst Caitlin Cronin maintains Axogen with a Buy and raises the price target from $24 to $27.

Просмотреть больше
Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $27
Analyst Upgrades

Citizens Maintains Market Outperform on Axogen, Raises Price Target to $34

Citizens analyst David Turkaly maintains Axogen with a Market Outperform and raises the price target from $26 to $34.

Просмотреть больше
Citizens Maintains Market Outperform on Axogen, Raises Price Target to $34
GlobeNewswire

Axogen, Inc. Reports Third Quarter 2025 Financial Results

ALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

GlobeNewswire

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025

ALACHUA, Fla. and TAMPA, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.